Table 4.
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Age | 1.06 | 1.01–1.12 | 0.014 | 1.03 | 0.98–1.10 | 0.236 |
PSA | 1.07 | 0.91–1.26 | 0.421 | |||
PV | 0.96 | 0.94–0.97 | 0.002 | |||
PSAD 0.1 increase | 1.72 | 1.29–2.36 | 0.0002 | 1.55 | 1.15–2.15 | 0.004 |
TT | 1.08 | 0.83–1.42 | 0.556 | |||
FT | 0.84 | 0.73–0.94 | 0.002 | 0.99 | 0.85–1.16 | 0.930 |
%FT 0.01 increase | 0.91 | 0.87–0.96 | <0.0001 | 0.93 | 0.88–0.98 | 0.009 |
When treating PSAD and %FT as continuous predictors, the odds ratio have been computed for a 0.1 increase in PSAD levels and a 0.01% increase in %FT levels. P value was calculated by likelihood ratio test.
CI, confidence interval; FT, free testosterone; %FT, percent free testosterone; OR, odds ratio; PSA, prostate-specific antigen; PSAD, PSA density; PV, prostate volume; TT, total testosterone.